CAPR — Capricor Therapeutics Share News
0.000.00%
Last trade - 00:00- $356.39m
- $118.46m
U.S. STOCKS ON THE MOVE-Synopsys, Cboe, GameStop
Capricor rises after promising 24-month data on Duchenne drug
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics
Piper Sandler upgrades Capricor Therapeutics, shares gain
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics
Capricor rises after US FDA extends review of muscle disorder therapy
Capricor's Duchenne drug gets three-month FDA extension after new data submission (updated)
US FDA extends review of Capricor's muscle disorder therapy by three months
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
Capricor jumps as FDA agrees to review fresh Duchenne drug data
Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes (updated)
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer
U.S. STOCKS ON THE MOVE-Reddit, Capricor Therapeutics, Birkenstock
Capricor more than doubles as FDA agrees to review fresh Duchenne drug data